This topic contains a solution. Click here to go to the answer

Author Question: Drug offenders who receive treatment behind bars are less likely to: a. recidivate. b. be ... (Read 73 times)

james0929

  • Hero Member
  • *****
  • Posts: 586
Drug offenders who receive treatment behind bars are less likely to:
 
  a. recidivate.
  b. be released from prison.
  c. adjust to prison.
  d. get along with others.

Question 2

Substance-involved inmates and sex offenders are considered:
 
  a. special offense inmates.
  b. special needs inmates.
  c. special populations inmates.
  d. none of these choices.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mirabriestensky

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

a

Answer to Question 2

a




james0929

  • Member
  • Posts: 586
Reply 2 on: Aug 17, 2018
YES! Correct, THANKS for helping me on my review


AmberC1996

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library